Trial intelligence / Profile preview

Bepantol Cream for Post-Laser Skin Recovery

NCT03852563Completed

Sponsor
Bayer
Start
Mar 2019
Primary completion
Apr 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dexpanthenol in erythema and surgical wound (2 arms), sponsored by Bayer. Primary endpoints: Skin barrier integrity by TEWL probe at 23 days and Dermic temperature by thermographic camera (FLIR) at 23 days. Started Mar 2019; status: completed.

02

Drugs

dexpanthenol
03

Conditions

erythemasurgical wound

Beyond the preview

Go deeper on NCT03852563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03852563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call